His decision came as an investigation into sexual harassment allegations against him was ongoing.
In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.
The Scientist
Most Recent
The announcement comes after an agency working group recommends against an industry partnership on ethical grounds.
Researchers use several different strategies to deliver a one-two punch.
The company’s recent effort to find new treatments for Alzheimer’s ended in disappointment.
The drug may worsen future infections for people who haven't already been exposed to the virus.
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
Three investigations reveal the influence of industry money in patient advocacy groups, treatment guidelines, and Twitter feeds.
The Swiss pharma giant is acquiring Oklahoma-based Selexys Pharmaceuticals, a maker of drugs for inflammatory and thrombotic diseases.
The state’s industry draws inspiration from medicine as well as agriculture.
Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.
Popular Now
-
The Nutshell Prominent Salk Institute Scientist Inder Verma Resigns -
The Nutshell Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study The company’s announcement comes weeks after enrollment was suspended.
-
The Nutshell Dartmouth Professor Investigated for Sexual Misconduct Retires Todd Heatherton had groped students, according to allegations, and was facing termination.
-
News Analysis North American Universities Increasingly Cancel Publisher Packages A growing number of libraries are unbundling their subscriptions to the full suite of publishers’ journals, opting for limited titles to save on costs.
Current Issue
© 1986-2018 The Scientist
